EpiVax Launches Precision Cancer Immunotherapy Venture … – Markets Insider
|
EpiVax Launches Precision Cancer Immunotherapy Venture …
Markets Insider PROVIDENCE, Rhode Island, Sept. 25, 2017 /PRNewswire/ — EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and … |
